Apyx Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Apyx Medical
APYX Stock  USD 3.46  0.10  2.81%   
Apyx Medical's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Apyx Medical's valuation are provided below:
Gross Profit
30 M
Profit Margin
(0.30)
Market Capitalization
143.2 M
Enterprise Value Revenue
3.2575
Revenue
47.9 M
We have found one hundred twenty available fundamental signals for Apyx Medical, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of Apyx Medical prevailing market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road. Market Cap is likely to drop to about 67.9 M in 2026. Enterprise Value is likely to drop to about 67.5 M in 2026

Apyx Medical Total Revenue

58.08 Million

Check Apyx Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Apyx Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 724.3 K, Interest Expense of 7.1 M or Selling General Administrative of 52.1 M, as well as many indicators such as Price To Sales Ratio of 1.28, Dividend Yield of 0.0 or PTB Ratio of 4.32. Apyx financial statements analysis is a perfect complement when working with Apyx Medical Valuation or Volatility modules.
  
Build AI portfolio with Apyx Stock
Check out the analysis of Apyx Medical Correlation against competitors.
For more information on how to buy Apyx Stock please use our How to Invest in Apyx Medical guide.

Apyx Medical Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets78.3 M74.6 M52.2 M
Slightly volatile
Short and Long Term Debt Total46.8 M44.6 M12.6 M
Slightly volatile
Total Current Liabilities12.9 M12.3 M7.8 M
Slightly volatile
Total Stockholder Equity24.1 M16.3 M31.7 M
Pretty Stable
Property Plant And Equipment Net5.4 M7.7 M6.6 M
Slightly volatile
Accounts Payable3.2 M3 M1.9 M
Slightly volatile
Cash38.3 M36.5 M21.6 M
Slightly volatile
Non Current Assets Total8.3 M9.7 M8.8 M
Very volatile
Non Currrent Assets Other2 M1.9 M867 K
Slightly volatile
Cash And Short Term Investments38.3 M36.5 M25.2 M
Slightly volatile
Net Receivables18.7 M17.8 M9.4 M
Slightly volatile
Good Will144.8 K212.8 K190.1 K
Slightly volatile
Common Stock Total Equity24.1 K31.5 K30.8 K
Very volatile
Common Stock Shares Outstanding22.9 M40.9 M27.5 M
Slightly volatile
Liabilities And Stockholders Equity78.3 M74.6 M52.2 M
Slightly volatile
Non Current Liabilities Total48 M45.8 M13.1 M
Slightly volatile
Inventory5.4 M8.7 M6.7 M
Slightly volatile
Other Current Assets1.4 M1.9 M1.8 M
Slightly volatile
Other Stockholder Equity111.2 M105.9 M58.5 M
Slightly volatile
Total Liabilities61 M58.1 M20.9 M
Slightly volatile
Property Plant And Equipment Gross13 M12.3 M7.7 M
Slightly volatile
Total Current Assets68.2 M64.9 M43.3 M
Slightly volatile
Short Term Debt286.5 K319.5 K273.3 K
Slightly volatile
Intangible Assets6.6 K6.9 K826.5 K
Slightly volatile
Common Stock24.4 K34.2 K31.2 K
Pretty Stable
Other Assets1.1 M1.4 M1.3 M
Pretty Stable
Property Plant Equipment5.8 M7.8 M6.5 M
Slightly volatile
Long Term Debt40.9 M39 M18.9 M
Slightly volatile
Other Liabilities1.8 M1.8 M1.9 M
Pretty Stable
Net Tangible Assets40.5 M43.2 M36.5 M
Slightly volatile
Long Term Debt Total360 K378.9 K2.8 M
Slightly volatile
Capital Surpluse51.5 M84.3 M51.1 M
Slightly volatile
Deferred Long Term Asset Charges21.4 K22.5 K502.8 K
Slightly volatile
Warrants3 M3.7 M3 M
Slightly volatile
Preferred Stock Total Equity855900719.9 K
Slightly volatile
Deferred Long Term Liabilities467.6 K349.2 K483.5 K
Slightly volatile
Short and Long Term Debt175.4 K126 K187.8 K
Slightly volatile
Net Invested Capital44.7 M43.3 M41.7 M
Slightly volatile
Net Working Capital40.2 M41.1 M35.2 M
Slightly volatile
Capital Stock38.3 K43.7 K35.2 K
Slightly volatile
Capital Lease Obligations5.9 M5.6 M2 M
Slightly volatile
Noncontrolling Interest In Consolidated Entity239.8 K242.7 K172.8 K
Slightly volatile

Apyx Medical Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization724.3 K688.9 K747.4 K
Very volatile
Interest Expense7.1 M6.8 M1.4 M
Slightly volatile
Selling General Administrative52.1 M49.6 M28.1 M
Slightly volatile
Total Revenue58.1 M55.3 M35 M
Slightly volatile
Gross Profit35.5 M33.8 M19.7 M
Slightly volatile
Other Operating Expenses80.8 M77 M46.4 M
Slightly volatile
Research Development6.1 M5.8 M3.1 M
Slightly volatile
Cost Of Revenue13.4 M21.6 M14.7 M
Slightly volatile
Total Operating Expenses58.2 M55.4 M31.2 M
Slightly volatile
Selling And Marketing Expenses23.7 M22.6 M8.5 M
Slightly volatile
Interest Income1.9 M1.8 M1.1 M
Pretty Stable
Discontinued Operations88.8 M84.5 M44.1 M
Slightly volatile
Extraordinary Items88.8 M84.5 M44.1 M
Slightly volatile
Reconciled Depreciation844.2 K688.9 K737.9 K
Slightly volatile

Apyx Medical Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow52.7 M50.2 M21.7 M
Slightly volatile
Depreciation724.3 K688.9 K747.4 K
Very volatile
Capital Expenditures906.1 K830.3 K657.4 K
Slightly volatile
End Period Cash Flow38.3 M36.5 M21.6 M
Slightly volatile
Stock Based Compensation4.8 M4.6 M2.5 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.281.345.3122
Slightly volatile
PTB Ratio4.324.5412.9239
Slightly volatile
Days Sales Outstanding11110688.156
Slightly volatile
Book Value Per Share0.340.361.0509
Very volatile
Average Payables557.5 K956.1 K987.8 K
Very volatile
Stock Based Compensation To Revenue0.04650.07510.0614
Slightly volatile
Capex To Depreciation1.391.20530.9668
Pretty Stable
PB Ratio4.324.5412.9239
Slightly volatile
EV To Sales1.431.514.96
Slightly volatile
Inventory Turnover3.272.852.4916
Pretty Stable
Days Of Inventory On Hand116133168
Very volatile
Payables Turnover13.328.249.5584
Slightly volatile
Sales General And Administrative To Revenue0.580.810.741
Slightly volatile
Average Inventory3.8 M3.7 M3.8 M
Slightly volatile
Research And Ddevelopement To Revenue0.05180.0950.0818
Slightly volatile
Capex To Revenue0.01640.01730.0227
Slightly volatile
Cash Per Share0.840.80.7672
Slightly volatile
Days Payables Outstanding31.5945.8349.439
Pretty Stable
Intangibles To Total Assets0.00220.00230.0381
Slightly volatile
Current Ratio3.824.745.5056
Very volatile
Receivables Turnover3.393.576.3319
Slightly volatile
Shareholders Equity Per Share0.340.361.0492
Very volatile
Debt To Equity2.582.460.7552
Slightly volatile
Capex Per Share0.02220.02340.0256
Slightly volatile
Average Receivables2.6 M2.5 M2.6 M
Slightly volatile
Revenue Per Share0.971.221.1962
Very volatile
Interest Debt Per Share1.191.130.3639
Slightly volatile
Debt To Assets0.560.540.1908
Slightly volatile
Graham Number10.129.648.8421
Slightly volatile
Operating Cycle166238253
Slightly volatile
Price Book Value Ratio4.324.5412.9239
Slightly volatile
Days Of Payables Outstanding31.5945.8349.439
Pretty Stable
Company Equity Multiplier5.515.252.7391
Very volatile
Long Term Debt To Capitalization0.670.630.3826
Slightly volatile
Total Debt To Capitalization0.690.660.2692
Slightly volatile
Debt Equity Ratio2.582.460.7552
Slightly volatile
Quick Ratio2.584.14.1916
Pretty Stable
Cash Ratio2.82.662.4915
Slightly volatile
Cash Conversion Cycle134192203
Slightly volatile
Days Of Inventory Outstanding116133168
Very volatile
Days Of Sales Outstanding11110688.156
Slightly volatile
Price To Book Ratio4.324.5412.9239
Slightly volatile
Fixed Asset Turnover6.198.215.1378
Slightly volatile
Debt Ratio0.560.540.1908
Slightly volatile
Price Sales Ratio1.281.345.3122
Slightly volatile
Asset Turnover1.240.850.8482
Slightly volatile
Gross Profit Margin0.380.550.5221
Slightly volatile
Price Fair Value4.324.5412.9239
Slightly volatile

Apyx Medical Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap67.9 M103 M107.2 M
Very volatile
Enterprise Value67.5 M100.9 M105.2 M
Very volatile

Apyx Fundamental Market Drivers

Apyx Upcoming Events

21st of March 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
21st of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Apyx Medical Financial Statements

Apyx Medical investors use historical fundamental indicators, such as Apyx Medical's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Apyx Medical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue623.7 K592.5 K
Total Revenue55.3 M58.1 M
Cost Of Revenue21.6 M13.4 M
Stock Based Compensation To Revenue 0.08  0.05 
Sales General And Administrative To Revenue 0.81  0.58 
Research And Ddevelopement To Revenue 0.10  0.05 
Capex To Revenue 0.02  0.02 
Revenue Per Share 1.22  0.97 
Ebit Per Revenue(0.45)(0.43)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
GOOGAlphabet Inc Class C
VVisa Class A
MSFTMicrosoft

Additional Tools for Apyx Stock Analysis

When running Apyx Medical's price analysis, check to measure Apyx Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apyx Medical is operating at the current time. Most of Apyx Medical's value examination focuses on studying past and present price action to predict the probability of Apyx Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apyx Medical's price. Additionally, you may evaluate how the addition of Apyx Medical to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY